Decreased lymphocyte proliferation is correlated with increased PD-1 and PD-1 ligand expression in septic shock patients

被引：0
|
作者：
Venet, Fabienne
Guignant, Caroline
Lepape, Alain
Ayala, Alfred
Monneret, Guillaume
机构：
来源：
INFLAMMATION RESEARCH | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A79
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] Programmed death receptor 1 (PD-1) ligand Fc fusion proteins reduce T-cell proliferation in vitro independently of PD-1
    Biemond, Melissa
    Vremec, David
    Gray, Daniel H. D.
    Hodgkin, Philip D.
    Heinzel, Susanne
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (02): : 117 - 130
  • [22] Mouse PD-1 expression and function
    Alaverdi, N
    Iwai, Y
    Honjo, T
    FASEB JOURNAL, 2002, 16 (04): : A710 - A710
  • [23] The Expression of the Co-Inhibitory Molecule PD-1 and Its Ligand PD-L1 in Patients with MDS
    Geng, Suxia
    Weng, Jianyu
    Huang, Xin
    Wu, Ping
    Deng, Chengxin
    Lai, Peilong
    Du, Xin
    BLOOD, 2015, 126 (23)
  • [24] Programmed Death-1 (PD-1) Receptor/PD-1 Ligand (PD-L1) Expression in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Michal, Michal
    Hes, Ondrej
    LABORATORY INVESTIGATION, 2017, 97 : 211A - 211A
  • [25] Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis
    Atesoglu, Elif Birtas
    Tarkun, Pinar
    Demirsoy, Esra Terzi
    Geduk, Ayfer
    Mehtap, Ozgur
    Batman, Adnan
    Kaya, Fatih
    Cekmen, Mustafa Baki
    Gulbas, Zafer
    Hacihanefioglu, Abdullah
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (03) : 248 - 251
  • [26] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Mundo, Enric Condom
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Dusek, Martin
    Hora, Milan
    Michal, Michal
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 : 17 - 22
  • [27] PD-1 and PD-1 ligands: from discovery to clinical application
    Okazaki, Taku
    Honjo, Tasuku
    INTERNATIONAL IMMUNOLOGY, 2007, 19 (07) : 813 - 824
  • [28] Expression of PD-L1 and PD-1 in Cutaneous Warts
    Yu, Wesley
    Berger, Timothy
    Laszik, G. Zoltan
    North, Jeffrey
    Cohen, Jarish
    LABORATORY INVESTIGATION, 2019, 99
  • [29] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [30] PD-1 and PD-L1 expression in cardiac transplantation
    Bishawi, Muath
    Bowles, Dawn
    Pla, Michelle Mendiola
    Oakes, Faye
    Chiang, Yuting
    Schroder, Jacob
    Milano, Carmelo
    Glass, Carolyn
    CARDIOVASCULAR PATHOLOGY, 2021, 54
12345